The Pershing Square Sohn Cancer Research Alliance funds early-career US scientists for bold, high-risk cancer research with transformative potential, supporting innovation and collaboration in the field.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years); minimum of six awards annually
Summary: Supports early-career scientists in the US conducting innovative, high-risk cancer research with transformative potential.
Key Information: Application is a two-stage process (LOI + finalist presentation); open to all US institutions.
The Pershing Square Sohn Cancer Research Alliance Initiative provides substantial funding to early-career scientists pursuing bold, high-risk, and high-reward projects in cancer research. The program aims to accelerate breakthroughs by supporting independent investigators at a pivotal stage in their careers, enabling them to pursue ideas that may not be eligible for traditional funding. In addition to funding, awardees join a collaborative network, gaining access to mentorship, industry connections, and opportunities to present their work at conferences and events. The initiative is open to researchers at academic institutions across the United States.